NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage
The company targets all current ketamine indications, including anesthesia and pain management. The U.S. is facing a severe ketamine shortage,…